CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 8-K Event Material agreement · Unregistered share sale · Shareholder vote results · Other events
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Agreement ended
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Delisting notice
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 4 Shares withheld for taxes Sr. VP of Finance gave up 180 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
Page 7 of 77 · 1,525 filings